383 related articles for article (PubMed ID: 33372616)
1. French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).
Terrier B; Darbon R; Durel CA; Hachulla E; Karras A; Maillard H; Papo T; Puechal X; Pugnet G; Quemeneur T; Samson M; Taille C; Guillevin L;
Orphanet J Rare Dis; 2020 Dec; 15(Suppl 2):351. PubMed ID: 33372616
[TBL] [Abstract][Full Text] [Related]
2. Granulomatous Vasculitis.
Sharma A; Dogra S; Sharma K
Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
[TBL] [Abstract][Full Text] [Related]
3. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
[TBL] [Abstract][Full Text] [Related]
4. [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].
Arnold S; Klapa S; Holl-Ulrich K; Müller A; Kerstein-Stähle A; Lamprecht P
Z Rheumatol; 2022 Sep; 81(7):558-566. PubMed ID: 35962194
[TBL] [Abstract][Full Text] [Related]
5. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the Peripheral Nervous System in Polyarteritis Nodosa and Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.
Imboden JB
Rheum Dis Clin North Am; 2017 Nov; 43(4):633-639. PubMed ID: 29061248
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
[TBL] [Abstract][Full Text] [Related]
8. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
[TBL] [Abstract][Full Text] [Related]
9. [Cortisone-free rheumatology-Vasculitides].
Holle JU; Moosig F
Z Rheumatol; 2021 May; 80(4):314-321. PubMed ID: 33709164
[TBL] [Abstract][Full Text] [Related]
10. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis.
Frankel SK; Sullivan EJ; Brown KK
Crit Care Clin; 2002 Oct; 18(4):855-79. PubMed ID: 12418444
[TBL] [Abstract][Full Text] [Related]
11. How to improve the histopathological diagnosis of systemic vasculitides in daily practice?
Honsová E
Cesk Patol; 2020; 56(2):68-73. PubMed ID: 32493022
[TBL] [Abstract][Full Text] [Related]
12. When should immunosuppressants be prescribed to treat systemic vasculitides?
Guillevin L; Pagnoux C
Intern Med; 2003 Apr; 42(4):313-7. PubMed ID: 12729318
[TBL] [Abstract][Full Text] [Related]
13. Brief Report: Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data From the French Vasculitis Study Group Registry.
Iudici M; Puéchal X; Pagnoux C; Quartier P; Agard C; Aouba A; Büchler M; Cevallos R; Cohen P; de Moreuil C; Guilpain P; Le Quellec A; Roblot P; Serratrice J; Bachmeyer C; Daugas É; Terrier B; Mouthon L; Guillevin L;
Arthritis Rheumatol; 2015 Jul; 67(7):1959-65. PubMed ID: 25808634
[TBL] [Abstract][Full Text] [Related]
14. [ANCA-associated vasculitis].
Holle JU
Internist (Berl); 2015 Jan; 56(1):41-50; quiz 51-2. PubMed ID: 25502657
[TBL] [Abstract][Full Text] [Related]
15. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature.
Rothschild PR; Pagnoux C; Seror R; Brézin AP; Delair E; Guillevin L
Semin Arthritis Rheum; 2013 Apr; 42(5):507-14. PubMed ID: 23270762
[TBL] [Abstract][Full Text] [Related]
17. Treatment of systemic necrotizing vasculitides: recent advances and important clinical considerations.
Pagnoux C; Mendel A
Expert Rev Clin Immunol; 2019 Sep; 15(9):939-949. PubMed ID: 31414912
[No Abstract] [Full Text] [Related]
18. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
Tervaert JW; Limburg PC; Elema JD; Huitema MG; Horst G; The TH; Kallenberg CG
Am J Med; 1991 Jul; 91(1):59-66. PubMed ID: 1677531
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognostic factors in an Argentinian cohort with ANCA-associated vasculitis.
Pérez N; Gargiulo MLÁ; Suarez L; Khoury M; Gómez G
Medicina (B Aires); 2021; 81(2):198-207. PubMed ID: 33906138
[TBL] [Abstract][Full Text] [Related]
20. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis.
Kawakami T
J Dermatol; 2010 Feb; 37(2):113-24. PubMed ID: 20175844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
